Skip to main content
Premium Trial:

Request an Annual Quote

Breakthrough Prize for mRNA, NGS Work

The University of Pennsylvania's Katalin Karikó and Drew Weissman, whose work on mRNA enabled the development of mRNA-based SARS-CoV-2 vaccines, have won the 2021 Breakthrough Prize in Life Sciences, LiveScience reports.

As LiveScience notes, Karikó and Weissman uncovered a way to modify synthetic mRNA so that it wouldn't alert the immune system, enabling it to enter cells and undergo replication before breaking down. This approach, the Guardian adds, was then used by Moderna and BioNTech, where Karikó is also senior vice president.

Also winning the 2021 Breakthrough Prize in Life Sciences are Shankar Balasubramanian and David Klenerman, both of the University of Cambridge, and Pascal Mayer from Alphanosos for their work developing next-generation sequencing, the Guardian reports. It adds that their work increased the speed and lowered the cost of DNA sequencing.

"It's had a massive impact and much more than we imagined when we were brainstorming this," Klenerman tells the Guardian. "We didn't expect it to become such a dominant technology."

The Breakthrough Prizes were established about a decade ago, with the goal of making " science as glitzy as rock 'n' roll," as the New York Times wrote in 2014The winners of the Breakthrough, New Horizons, and New Frontiers prizes receive $15.75 million in total, though the award event has been postponed until 2022 due to the COVID-19 pandemic.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.